1.
He Y, Wang P, Wei D. Feasibility Study of Yuejuwan as an Adjuvant Therapy for Primary Liver Cancer. JCMP [Internet]. 2024 Oct. 29 [cited 2024 Dec. 22];6(10):12-6. Available from: https://bryanhousepub.com/index.php/jcmp/article/view/713